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ABSTRACT
The roles that Plk4 plays in cell division and DNA damage pathways have not yet 
been clarified. Results presented provide further insight into this question. Plk4 protein 
levels were seen to decrease in response to UV damage specifically, but not ionizing 
radiation. Additionally, overexpression of Plk4 overrides the Gl-S checkpoint arrest 
induced by DNA damage, leading to an accumulation of cells in the S-phase of the cell 
cycle. This suggests that Plk4 is inhibited by DNA damage, and suggests a possible role 
for Plk4 in S-phase entry.
Thus far only a few interacting partners and substrates are known for Plk4. My 
results show that Plk4 interacts with both Cdc25C and Cyclin B. Furthermore, Cdc25C 
was established to be a substrate of Plk4 through in-vitro kinase assays. The finding that 
Plk4 interacts with these key mitotic proteins provides further evidence that Plk4 may 
play a novel role in cell division.
iii
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CHAPTER I
INTRODUCTION 
Polo-Like Kinase Family
The Polo-Like kinases (Plks) are a family of serine-threonine kinases which play 
key roles in multiple stages of the cell cycle (Glover et a l, 1998). The founding member 
of this family was named Polo and was originally identified in Drosophila melanogaster. 
Subsequently, structural and functional homologs have been identified in all major model 
systems studied, indicating a conserved function and evolutionarily important role in 
ensuring species survival. Simple eukaryotes such as Saccharomyces cerevisiae and 
Schizosaccharomyces pombe contain one Plk family member, CDC5 and Plol 
respectively (Kitada et al., 1993; Ohkura et al., 1995), while more complex eukaryotes 
contain a higher number of Plk family members. C. elegans and Xenopus laevis have 
three Plk family members, whereas humans and mice contain four (Plkl, Plk2, Plk3 and 
Plk4 or Sak) (Barr et al., 2003).
The Plks play important roles during multiple stages of the cell cycle including 
cytokinesis and mitosis as well as roles in DNA damage response pathways (Barr et al.,
2004). Furthermore, Plks are regulators of bipolar spindle formation, centrosome 
maturation, chromosome segregation and APC/C regulation (Barr et al., 2004).
The Polo-Box Domain
The Plks share two 
kinase domain and one or
1
highly homologous regions including an N-terminal protein 
two non-catalytic C-terminal polo-box domains (Figure 1).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Plks 1-3 contain two polo-box domains, whereas Plk4 only contains one. Each polo-box 
is -80 amino acids in length separated by a -20 amino acid linker region (Leung et al, 
2002; Cheng et al., 2003). Cheng et al, 2003 revealed that the two polo-boxes of Plkl 
contain a six-stranded anti-parallel beta-sheet and an alpha-helix.
Lie et al., 1998 suggested that the polo-box domain of Plkl is necessary for 
localization. A single amino acid change of a conserved residue at position 414 in the 
polo-box from tryptophan to phenylalanine abrogates P lk l’s localization to the spindle 
pole bodies. Furthermore, this mutation of the human Plkl polo-box domain results in 
P lkl’s inability to complement the temperature sensitive CDC5-1 mutant (Lee et al., 
1998). Complementation assays for the CDC5-1 mutant prove that W414 is the most 
crucial residue for the function of Plkl polo-box domain (Lie et al., 1998). Additionally, 
Hanisch et al., 2006 reported that the catalytic domain of Plkl, lacking the polo-box 
domain is unable to localize to centrosomes and kinetochores. Hanisch et al, 2006 also 
demonstrated that diminishing Plkl or similarly overexpression of the polo-box domain 
of Plkl resulted in mitotic arrest. Interestingly however, overexpression of the polo-box 
domain interfered with chromosome segregation whereas depletion of Plkl impaired 
maturation and separation of centrosomes or bipolar spindle formation (Hanish et al., 
2006). However, on the contrary, it was also found that Plkl protein in which both polo- 
box domains have been deleted still localizes to centrosomes as do the two polo-box 
domains of Plkl expressed as GFP (green fluorescent protein) fusion proteins. This thus 
suggests that the polo-box domains are sufficient but not necessary for localization 
(Hudson unpublished data). The polo-box domain of Plk3 has also been implicated as a 
localization signal to centrosomes and spindle poles (Jiang et al., 2006). Also, it has been
2
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shown that both polo-box motifs are necessary for this localization to occur and that the 
polo-box domain is also sufficient for this localization. In addition, overexpression of the 
polo-box domain of Plk3 interferes with cell division and cytokinesis (Jiang et al., 2006).
For P lk l-3, the polo-box domain including the region between them and a portion 
of the linker between the end of the kinase domain and the first polo-box domain, 
functions as a single phosphoserine/threonine-binding module (Elia et al, 2003a). The 
crystal structure of the Plkl polo-box domain showed that the phosphopeptide binding 
motif is located in the interface between the two polo-boxes (Cheng et al., 2003; Elia et 
al., 2003b). For Plkl, a molecular model has been proposed for the substrate binding of 
the kinase. The model proposes that initially the polo-box binds to a previously 
phosphorylated serine/threonine binding motif on the substrate which then positions the 
substrate such that the kinase domain of Plkl can phosphorylate the same protein at a 
different site (Figure 2a) (Elia et al., 2003a). The two residues of Plkl that come in 
contact with the phosphate group are H538 and K540 and mutation of these residues 
results in loss of substrate binding and localization of centrosomes (Cheng et al., 2003). 
If this model is accurate, Plkl substrates should contain polo-box binding motifs and 
kinase phosphorylation motifs. This model thus proves accurate for Plkl substrate 
Cdc25C. Cdc25C is phosphorylated on Thr-130 by Cdkl and this site is involved in the 
interaction with the polo-box domain. Upon binding, Plkl then phosphorylates Ser-198 
of Cdc25C (Elia et al., 2003a). Mutation of the putative Plkl pThr-binding motif in 
Cdc25C abolishes the interaction of the enzyme with its substrate (Elia et al., 2003a). 
Furthermore, mutation of the interaction sites within the polo-box domain of Plkl not 
only abrogates phospho-substrate binding, but also eliminates localization of Plkl to the
3
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centrosomes (Elia et al, 2003b). Also, quite interestingly, upon phospho-peptide binding 
of the polo-box domain of Plkl, Plkl kinase activity is also stimulated (Elia et al, 
2003b). One model for this is that Plkl activity is negatively regulated by the polo-box 
domain (Jang et al, 2002). In the absence of a phosphorylated substrate, the polo-box 
domain interacts with the kinase domain and prevents substrate binding or activation. 
Upon binding of the polo-box domain with a phosphopeptide, the kinase domain is thus 
released and upon phosphorylation of the T-loop, the protein is converted to an active 
form (Elia et al, 2003b).
An alternate model proposes that the polo-box domain phosphoserine / threonine 
substrates are essentially different from the substrates that the kinase domain 
phosphorylates. This model suggests that perhaps polo-box binding to phosphorylated 
docking proteins localizes the kinase domain to its substrates which may or may not be 
tightly associated with the docking protein (Figure 2b).
Trp-414, a key residue which is necessary for polo-box localization along with 
His-538 and Lys-540, residues which bind phosphorylated peptides, are conserved 
residues in Plk 1-3 however not in Plk4. Both Plk2 and Plk3 polo-box domains are found 
to function as phosphoserine/threonine binding motifs thus suggesting a similar 
mechanism of substrate interaction (Cheung et al, 2003).
4
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Kinase Domain Polo-box domain
Figure 1. Polo-like kinase structure. Plks share a highly conserved protein kinase domain 
in the amino-terminal and common structural motifs called polo-boxes in the non-catalytic 
carboxy-terminal region. The kinase domain is represented by the yellow colour and the 
two polo-boxes are shown in red. The region prior to and including the two polo-boxes has 
been renamed the polo-box domain.
5
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Figure. 2. Two models for Plkl, Plk2 and Plk3 polo-box domain function. Plks 1-3 are 
activated through phosphorylation of T-210 and binding of the polo-box domain to 
phosphorylated ligands. Which event occurs first remains to be elucidated. KD refers to the 
kinase domain and PBD refers to the polo-box domain. A. The polo-box domain binds to a 
site on a protein that has been previously phosphorylated by a priming kinase. This 
alleviates inhibition of the kinase domain and allows for phosphorylation of the same 
protein on a different site. B. In this model, the ligand to which the polo-box domain binds 
is different from the substrates which the kinase domain phosphorylates. Priming kinases 
phosphorylate sites on docking proteins and upon binding to the polo-box domain allows 
the catalytic domain of the Plk to phosphorylate the associated substrate.
6
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Activation and Phosphorylation of Plks
Although it is widely known that the Plks require phosphorylation for activation, 
their upstream activating kinases have remained fairly elusive. Among the Plks, the 
mechanistic and structural detail of Plkl activation has been the most extensively 
examined. The activation of other Plk family members is thought to occur through the 
same mechanism (Qian et al., 1999).
A common mechanism for the activation of many protein kinases is 
phosphorylation in their respective T loop. Within the kinase domains of Plks, several 
conserved serine and threonine residues are present which could be potential sites for 
phosphorylation and activation of these kinases. T210 lies within the T-loop of the Plk 
kinase domain and mutation of this residue to Asp mimics phosphorylation and renders 
the kinase constitutively active. It is generally believed that phosphorylation at T210 is a 
requirement for Plk activation (Qian et al., 1999).
Although much remains to be elucidated regarding the full activation of Plks, two 
candidates have been proposed for the phosphorylation of T210. These two candidates 
are human SLK and PKA along with Xenopus Plkkl (Qian et al, 1998).
Although mutation of another site in the kinase domain, S I37 to Asp also renders 
the kinase active, there is no evidence for the direct phosphorylation of this residue. 
Furthermore, mutation of this serine (SI37) to alanine did not prevent activation of 
Plkl/Plxl suggesting that phosphorylation at this residue occurs, but it is not critical 
(Qian et al., 1999). The possibility for additional post-translationally modified sites on 
Plks remains to be determined.
7
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Plk Expression and Localization
The expression and localization patterns of Plks are dynamically regulated in a 
cell-cycle dependent manner. Drosophila Polo localizes to centrosomes at mitotic entry. 
Furthermore, during prometaphase, the protein associated with kinetochores and late in 
anaphase, prior to cytokinesis, it was seen to localize to the central spindle (Glover,
2005).
Yeast Plks have been shown to localize to spindle pole bodies but the timing of 
localization differs between CDC5 (budding yeast) and Plol (fission yeast). CDC5 
localizes to the spindle pole bodies in G1 until the completion of mitosis (Song et al., 
2000). Conversely, Plol localizes to the spindle pole bodies only upon activation of 
Cdc2 and remains associated there until Cdc2 becomes inactive (Mulvihill et al, 1999).
During G2, Plkl localizes to the cytoplasm and the nucleus and is targeted to 
centrosomes (Golsteyn et al., 1995). During prophase and metaphase Plkl has been 
shown to localize to centrosomes and kinetochores where it persists until it is degraded. 
A portion of Plkl relocalizes to the equatorial spindle midzone at anaphase (Lee et al., 
1998). Generally, Plkl expression and activity is low in GO, G1 and S, begins to increase 
in G2 and peaks in M phase. Finally, Plkl is degraded through the ubiquitin - proteasome 
pathway upon completion of mitosis (Lee et al, 1995)
Plk2 and Plk3 most likely have overlapping roles with Plkl as they localize to 
similar intracellular structures. However, Plk2 functions predominantly as a regulator of 
G1 progression in mammalian cells (Ma et al., 2003a). Plk2 and Plk3, similar to Plkl, 
have both been shown to localize to the centrosomes (Wang et al., 2002). In contrast to 
what is found for Plkl and Plk2, the expression of Plk3 protein and mRNA is not cell
8
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cycle regulated. Although Plk3 mRNA expression is only seen in G l, Plk3 protein level 
is seen at all stages of the cell cycle given Plk3s stability (Alberts and Winkles, 2004). 
Furthermore, Plk3 protein is rapidly degraded in the nucleus via the ubiquitin-proteosome 
pathway however, in order to sustain a long half-life, plk3 is most likely sequestered in 
the cytoplasm in a catalytically inactive form.
The multiple sites of the Plks localization patterns and differential expression 
during normal cell cycle progression reflect the many functions that these enzymes 
perform during the cell cycle.
Plk Overexpression and Mutant Phenotypes
Mutations in Drosophila melanogaster Polo, the founding member of the Plk 
family, resulted in several phenotypic defects (Sunkel and Glover, 1988). Although 
homozygous mutants of the gene successfully developed to adulthood, numerous mitotic 
defects were observed during development (Glover, 2005). Additionally, monopolar 
spindles were observed in the mutant cells with centrosomes which failed to separate 
(Llamazares et al., 1991). In the absence of Polo function, several proteins fail to be 
recruited to the spindle pole and abnormal spindle poles form, reflecting the name of this 
protein (Llamazares et al, 1991).
Both the budding yeast and the fission yeast contain Polo homologs with 
significant functional similarities to vertebrates Plks suggesting that the role of Plks is 
largely preserved throughout evolution (Glover et al., 1998). A temperature-sensitive 
CDC5 mutant (the Plk homolog in budding yeast) arrests with a bipolar spindle late in 
mitosis (Byers et al., 1974). Furthermore, in the first division of meiosis, it displays
9
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abnormal behaviour of spindle pole bodies, and in the second division there is a failure of 
the spindles to elongate (Schlid et al., 1980). Interestingly, studies by Lee et al., 1997 
showed that complementation of the temperature sensitive CDC5-1 mutant could be 
accomplished by Plkl. Additionally, Ouyang et al., 1997 showed that Plk3 could also 
rescue this mutant, indicating that Plkl and Plk3 have a conserved function in regulating 
mitotic/meiotic progression. Thus, this demonstrates that Plkl and Plk3 both have 
conserved some CDC5 functions. In contrast, Plk2 and Plk4 do not rescue this mutant 
suggesting divergence of these Plk family members. Furthermore, this suggests that Plk2 
and Plk4 have a non-redundant role in the cell cycle (Swallow et al., 2005).
In fission yeast overexpression, or mutation of Plol resulted in the failure of the 
spindle pole bodies to complete either their duplication or separation resulting in 
monopolar spindles thus indicating the protein is necessary for bipolar spindle formation 
(Ohkura et al., 1995). Also, Plol mutants failed to form the actin ring and septum, both 
of which are prerequisites for cytokinesis. Another consequence of overexpression of 
Plol was multiple septa being formed in cells at any stage of the cell cycle (Ohkura et al., 
1995).
Vertebrate Plk family member’s knockdown and overexpression phenotypes have 
also been extensively examined. With respect to the Plkl knockdown phenotype, 
prominent mitotic arrest was observed. Although Plkl was dispensable for normal 
mitotic entry in human cells, as the majority of cells entered mitosis, Plkl depleted cells 
failed to exit mitosis (Van Vugt et al., 2004). Furthermore, upon entry into mitosis, Plkl 
deficient cells were unsuccessful at forming a bipolar spindle and were incapable of 
aligning their chromosomes. The inability for the cells to align their chromosomes is
10
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most likely caused by a defect in centrosome maturation, consistent with the observation 
that the Plks play key roles in the centrosome cycle (Seong et al., 2002; Llamazares et al., 
1991). Indeed, Li et al., 2002 did report that cells depleted of Plkl by RNAi displayed an 
inhibition in centrosome amplification. Additionally, downregulation of Plkl expression 
or activity in tumour cells induced apoptosis and inhibited tumour cell proliferation (Gray 
et al., 2004). On the other hand, overexpression of Plkl leads to multinucleation and 
enables tumour cells to override mitotic checkpoints leading to genomic instability and 
oncogenic transformation (Gray et al., 2004).
In contrast to Plkl, overexpression of Plk3 leads to apoptosis and suppresses 
cellular proliferation and inhibits colony formation (Conn et al., 2000). The Plk2 
knockdown phenotype has been examined as well, and downregulation of Plk2 by RNAi 
has shown that Plk2 is required for centriole duplication (Wamke et al., 2004). 
Furthermore, Plk2 knockout mice are viable and fertile, however they appear smaller then 
their wildtype littermates. Plk2-/- mice reveal a role for Plk2 in embryonic development, 
as the null embryos display a slight delay in development and exhibit a diminished 
weight of the placentas (Ma et al., 2003).
Plks and Centrosome Amplification
Localization and mutant phenotypes of polo-like kinases reveal a common 
characteristic role for Plks in bipolar spindle formation and centrosome duplication.
Drosophila Polo mutants fail to recruit key proteins to the centrosomes during 
centrosomal maturation. A complex of y-TuRC and CP 190 shows failure of recruitment 
to centrosomes in Polo mutants. This complex is responsible for capping the minus ends
11
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of microtubules on centrosomes a necessary step for their nucleation (Barbosa et al,
2000). Furthermore, Donaldson et al., 2001 show that RNAi directed towards Polo 
results in failure of y-tubulin recruitment to centrosomes. Another protein, Asp (a 
microtubule associated protein) has been found to be a substrate of Polo. Asp is 
necessary for microtubule-nucleating activity. Although Asp is able to localize in the 
absence of Polo, Polo is necessary to activate Asp at the microtubules (Avides et al.,
2001).
Fission Yeast Plk family member Plol associates with spindle poles and Finl has 
a role in this association. Finl is necessary for the regulation of spindle formation. 
Furthermore, increasing the levels of Finl results in recruitment of Plol to the spindle 
pole bodies in wild-type cells (Grallert et al., 2002). One hypothesis is that Finl may 
phosphorylate proteins at the spindle pole bodies providing docking sites for Plol 
(Grallert et al., 2002).
Xenopus Plxl immunodepletion resulted in monopolar spindles with altered 
patterns of a-tubulin around the pole (Qian et al., 1998). The mechanism through which 
this occurs is not completely understood, however it is thought that Plxl affects bipolar 
spindle formation through the regulation of centrosome maturation and separation.
Plkl has been shown to be necessary for the localization of several proteins to the 
centrosomes during the centrosome maturation process. Lane et al., 1996 proved that 
injection of Plkl antibodies into cells resulted in a decrease in the accumulation of y- 
tubulin at the centrosome suggesting that Plkl is necessary for y-tubulin localization. 
Furthermore, the cells had monoastral microtubule arrays and duplicated centrosomes 
which were not separated (Lane et al., 1996). Plkl has also been shown to interact with
12
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and phosphorylate a  and p-tubulins as well (Feng et al., 2002). Another centrosomal 
protein which Plkl has been shown to interact with is Nip (ninein-like protein) (Casenghi 
et al., 2003). This protein interacts with y-tubulin and contributes to the organization of 
microtubules. Plkl has been shown to phosphorylate Nip at the commencement of 
mitosis resulting in the proteins disengagement from centrosomes. Mutation of the Plkl 
phosphorylation sites in Nip hindered spindle formation (Casenghi et al, 2003). Thus, it 
is evident that Plkl is necessary for bipolar spindle formation and centrosome maturation 
and separation.
It is therefore evident, that the polo-like kinase family plays a key role in bipolar 
spindle formation and centrosome (spindle pole body) maturation and separation.
Plks and Cytokinesis
Another common role for Plks is their involvement in cytokinesis. Yeast Plk Plol 
activity is necessary for formation of a division septum whereas overexpression of this 
kinase leads to ectopic septum formation (Ohkura et al., 1995). Furthermore, Bahler et 
al, 1998 show that Plol interacts with Midl/Dmfl. Midl/Dmfl is a protein required for 
positioning of the cell division site. Plol localizes Midl/Dmfl to filamentous actin 
during mitosis from the nucleus (Sohrmann et al, 1996). Two main components of 
septation are equatorial actin ring formation and equatorial microtubule organizing center 
(EMTOC) formation which is similar to the central spindle that forms in animal cells 
(Heitz et al, 2001). Plol is necessary for EMTOC assembly and thus, Plol seems to be 
involved in several pathways which initiate septation (Heitz et al., 2001).
13
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Weak loss-of-function alleles of Drosophila polo kinase Polo display defects in 
cytokinesis (Carmena et al., 1998). Polo associates with a motor protein Pavarotti 
(Adams et al., 1998). Pavarotti (Pav) mutations result in a defective spindle mid-zone 
region and prevent cytokinesis from occurring (Carmena et al., 1998). Additionally, Pav 
and Polo are dependent on one another for their correct localization. Mutation of either 
protein results in failure of the other to localize to spindle poles and spindle mid-zone 
(Adams et al., 1998).
Xenopus Plxl is localized to the midbody in late mitosis (Qian et al., 1999) 
providing a role for this kinase in cytokinesis. Qian et al., 1998 showed that injection of 
mRNA encoding a kinase active form of Plxl into Xenopus embryos resulted in cleavage 
arrest. Embryos injected with wild-type Plxl however divided normally. Therefore, the 
inactivation of Plxl may be required for completion of cytokinesis in Xenopus embryos.
Mammalian Plks have also been implicated in cytokinesis. Initial support for the 
idea that Plkl was involved in cytokinesis came from the discovery of the Plkl substrate 
CHOl/MKLP-1 (mitotic kinesin-like protein) which induces microtubule bundling (Lee 
et al., 1995). Additionally, overexpression of a dominant negative form of Plkl causes 
cytokinesis failure, similar to the effect which is seen with the depletion of Plkl in cells 
(Van Vugt et al., 2004). Numerous other cytokinesis proteins were found to be 
phosphorylated by Plkl. Phosphorylation of NudC (nuclear distribution gene C) by Plkl 
is essential for the execution of cytokinesis (Zhou et al., 2003). Another protein which 
Plkl phosphorylates is MKLP2. When MKLP2 is phosphorylated, it binds to the polo- 
box domain of Plkl. Depletion of the protein results in failure of cytokinesis and 
furthermore, disrupts Plkl localization.
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Thus, the polo-like kinase family of mitotic regulators are important regulators of 
cytokinesis.
Plk4 (Sak) Structure
Plk4 (Sak) was the last member of the human Plk family to be identified. Human 
and murine Plk4 contain a highly conserved kinase domain and a less conserved polo-box 
domain (Figure 3). Although little is known about the kinase activity of this protein, a 
Plk4 T170D mutation in the T-loop increases kinase activity, whereas a Plk4 K41M 
mutation in the ATP-binding domain eliminates activity (Swallow et al., 2005).
Although Plks 1-3 are quite similar with respect to structure, Plk4 differs in that it 
harbours only a single polo-box motif at its extreme C-terminus (Leung et al, 2002). 
The Plk4 polo-box forms intermolecular homodimers and consists in total of two alpha 
helices and two six-stranded antiparellel beta sheets. Each beta sheet contains four 
strands from one polo-box and two strands coming from the other polo-box. Although 
there are several similaries between the polo-box domain of Plkl and Plk4 numerous 
differences also exist. Though each of the Plkl polo-box domains consists of one six- 
stranded beta sheet and an alpha helix, the organization of the strands between Plkl and 
Plk4 are strikingly different (Leung et al., 2002; Elia et al, 2003b). The two polo-box 
domains of Plkl form an intramolecular heterodimer and in contrast to Plk4, the Plkl 
beta-sheet consisted of six-self contained strands, and no strand exchange was observed. 
Although the polo-box region of Plk4 forms intermolecular homodimers, there is no 
evidence suggesting that the Plk4 polo-box binds phosphorylated peptides which is seen 
in the other Plk family members. Furthermore, the Plk4 polo-box domain is most likely
15
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not involved in substrate binding, as the residues which are most likely involved in 
phosphopeptide binding by Plkl are not conserved in Plk4 (Elia et al., 2003b). However, 
Swallow et al., 2005 report that the Plk4 polo-box domain is necessary but not sufficient 
for Plk4 binding to its substrate p53, suggesting that the polo-box region is a requirement 
for the binding of the protein to its substrate and interactions between subdomains of Plk4 
are important for binding. However, results published by Habedanck et al., 2005 and 
Leung et al., 2002, support the idea that in contrast to the other Plk family members, loss 
of the polo-box domain of Plk4 does not abolish localization. Subcellular localization 
loss was only seen if a second self-association domain denoted the ‘cryptic polo-box’ was 
also deleted (Habedanck et al., 2005).
The C-terminus of Plk4 contains three PEST sequences. PEST sequences are 
associated with decreased protein stability and the short half-life of proteins. Indeed, 
Plk4 does display a short half-life and the protein is destroyed by the anaphase-promoting 
complex (APC/C) following mitosis. Stability of this kinase is increased when the PEST 
sequences are deleted. Protection from PEST-dependent proteolysis and enhanced 
phosphorylation of the Plk4 kinase domain is observed upon Tec tyrosine kinase binding 
to the cryptic polo-box of Plk4. Subsequently, Plk4 is tyrosine phosphorylated by Tec 
(Yamashita et al., 2001). Tec is the only known kinase that phosphorylates Plk4.
16
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Kinase domain Cryptic-Pb Pb
Pest 1 Pest 2 Pest 3
Figure 3. Murine Plk4 structure. Plk4 contains a kinase domain at the N-terminus, one 
polo-box domain at the C-terminus and 3 PEST sequences. Upstream of the polo-box 
domain is another self-association domain designated the cryptic-polo-box.
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Plk4 Expression and Localization
Immunofluorescence staining has shown that endogenous Plk4 co-localizes with 
centrosomes throughout the cell cycle (Habedanck et al., 2005). Both the protein and 
mRNA levels of Plk4 are regulated in a cell cycle dependent fashion, quite similar to the 
other Plk family members. Plk4 expression increases gradually from G1 to early mitosis 
after which it is destroyed by the anaphase promoting complex (Fode et al., 1996). In 
mice there are two splice variants produced due to alternative splicing which results in 
the retention of an intron, followed by early termination of transcription in the Plk4-6 
transcript. Specifically, Plk4-a and Plk4-6 transcripts both have exons 1-5 present 
however at which point the transcripts differ. Exons 6-15 complete Plk-a, whereas 147 
base pairs adjacent to exon 5 completes Plk-6 (Hudson et al., 2000). In contrast, human 
Plk4 has only one transcript which has an insertion of 34 amino acids immediately 
contiguous to exon 5 relative to the murine Plk4-a protein sequence. Interestingly, this 
34 amino acid insertion in human Plk4 is highly similar to the intron sequence that is 
retained in murine Plk-6 (Hudson et al., 2000). All of the work in the present study will 
focus on human Plk4 constructs.
Plk4 Null Phenotype
Plk4 was the first polo-like kinase family member to be mutated in vertebrates. 
The murine Plk4 null phenotype was found to be embryonic lethal with embryos 
arresting at E7.5, shortly after gastrulation. Staining for the mitotic markers 
phosphorylated histone H3 and Cyclin B1 showed that a large percentage of the cells 
were blocked in mitosis. Phosphorylated histone H3 is rapidly dephosphorylated upon
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completion of mitosis. The Plk4 null embryos stained positive for phosphorylated 
histone H3 at a much higher frequency then Plk4 wildtype embryos indicating a block or 
delay in exit from mitosis. Also non-degradable forms of Cyclin B1 were seen in 
anaphase and telophase inhibiting exit from mitosis in Plk4 null embryos but not in Plk4 
wildtype embryos (Hudson et al, 2001). Proteolysis of cyclin B1 begins as soon as the 
last chromosome aligns on the metaphase plate and is complete prior to the onset of 
anaphase. Cyclin B1 degradation is required for the onset of anaphase and thus non- 
degradable forms blocks the exit of cells from mitosis (Clute et al, 1999). Therefore, 
Plk4 deficiency leads to an arrest or delay of cell cycle progression in mitosis (Hudson et 
al., 2001). Plk4 null embryo explants displayed a similar phenotype. Blastocyst 
outgrowths stained positive for phosphorylated histone H3 and Cyclin B1 and displayed 
an increase in dumbbell-shaped cells blocked in anaphase or telophase (Hudson et al,
2001). These results suggest that Plk4 is necessary for exit from mitosis and more 
importantly, that Plk4 is essential for cell viability.
Plk4 and Cancer
Plk4 heterozygous mice embryonic fibroblasts (MEFs) also have a unique 
phenotype when compared to wild-type MEFs. Plk4+/‘ MEFs have a much slower growth 
rate, an increased number of centrosomes, abnormal spindles, as well as misaligned and 
misdirected chromosomes. Thus haploid levels of Plk4 are not sufficient to sustain 
wildtype Plk4 phenotype and lead to chromosome instability (Hudson et al., 2001; Ko et 
al., 2005).
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The phenotype of Plk4 heterozygous mice was also examined. Despite the fact 
that Plk4 heterozygous mice have no evident abnormalities at a young age, with increased 
age, the heterozygous mice develop obvious tumours at a rate of 50% compared to only 
3% of their wildtype litter mates (Hudson et al., 2001; Ko et al., 2005). Primary 
heptaocellular carcinoma was the predominant category of tumour formation. The 
second most common lesions were papillary adenocarcinomas in the lungs. Additionally, 
several mice also developed axilla and upper chest wall tumours (Ko et al., 2005). 
Human PLK4 is found on chromosome 4q28. Intriguingly, loss or rearrangement of 
human chromosome 4q28 is common in hepatomas, the same region where PLK4 is 
located (Ko et al., 2005).
Furthermore, a two-thirds partial hepatectomy (PH) model was utilized to 
examine liver regeneration in Plk4 heterozygous and wildtype mice. Interestingly, at 44 
hours the Plk4 heterozygous hepatocytes displayed enlarged cellular and nuclear area 
compared to the wildtype hepatocytes (Ko et al., 2005). This is indicative of cells which 
experience a delay in the cell cycle. Furthermore, at 7 days post-PH the Plk4 +/- 
hepatocytes had atypical morphology compared to the wildype, with the liver architecture 
distorted. Also, the first cell cycle following PH in Plk4 heterozygous hepatocytes 
resulted in a delay of cell cycle progression and in particular a loss in the correct levels of 
Cyclin B, D and E. At 9-12 months, all of the Plk4+/‘ mice had abnormal liver histology 
and 4 of 11 mice had grossly apparent liver tumours. The tumours from Plk4+/' mice 
retained their heterozygosity at four polymorphic markers suggesting that the tumours 
were a result of Plk4 haploinsufficiency. These results all suggest that Plk4
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heterozygosity may be linked to hepatoma development and that deregulation of this 
kinase can contribute to carcinogenesis (Ko et al., 2005).
Plk4 and Centrosome Duplication
Dating back to 1914, Theodor Boveri proposed the idea that there was a 
relationship between the loss of tissue architecture typical of human tumors, aneuploidy 
and centrosomal abnormalities (Boveri et al., 1914). One mechanism in which Plk4 may 
lead to tumour progression is through centriole overduplication. Endogenous Plk4 
localizes to centrosomes throughout the cell cycle. Interestingly, centriole amplification 
occurs in Plk4 heterozygous MEF’s and also with the overexpression of Plk4 (Hudson et 
al, 2001; Ko et al., 2005; Habedanck et al., 2005).
There are two mechanisms in which centrosome overduplication can occur. 
These two mechanisms include legitimate centriole overduplication in S phase or through 
failure of cell division (Nigg et al., 2002). Interestingly, overexpression of Plk4 caused 
centrosome overduplication in the presence or absence of aphidicolin which blocks the 
cells in the S phase of the cell cycle. This indicates that Plk4 indeed caused legitimate 
centriole overduplication in S phase, rather then through failure of cell division 
(Habedanck et al., 2005). Furthermore, centrosome localization of Plk4 required regions 
of the protein that were located upstream of the polo-box domain, in the C-terminal non- 
catalytic domain and centriole amplification could only occur with the kinase domain 
present. Mutants which lacked the kinase domain or the C-terminal region could not 
cause centriole amplification (Habedanck et al., 2005). Additionally, overexpression of 
Plk4 only caused centrosome duplication in the presence of Cdk2. To that end, in the
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absence of Plk4, Cdk2 could not cause centrosome overduplication either. Thus, these 
two proteins must cooperate to cause the centrosome over duplication phenotype which is 
observed with the overexpression of Plk4 (Habedanck et al, 2005).
Loss of function experiments determined that indeed Plk4 is essential for centriole 
amplification. When endogenous Plk4 is depleted in cells, the centrosome amplification 
phenotype is suppressed. Also, cells undergo a reduction in centrosome number with 
each passage through the cell cycle with a predominant phenotype of monopolar spindles 
with a single centriole in the center 48 hours post Plk4 siRNA (Habedanck et al., 2005). 
Thus, with continued passage through the cell cycle, cells depleted of Plk4 undergo a 
reduction of centrioles indicating that Plk4 is indispensable for centriole duplication 
(Habedanck et al., 2005).
Plk4 heterozygous MEF’s also display a similar phenotype such that centrosome 
overduplication is observed. One possible explanation for this is believed to be that Plk4 
heterozygous MEF’s fail to restrict Cyclin E and Cdk2, which results in overduplication 
of centrosomes. This could possibly be an outcome of the decreased p53 and p21 levels 
seen in Plk4 heterozygous MEF’s (Ko et al., 2005). Another explanation for this 
phenotype could be that reduced Plk4 activity causes cell division failure and thus 
centrosomes are overduplicated or vise versa such that cell division failure results as a 
consequence of irregular centrosome duplication (Habedanck et al., 2005). Increased 
centrosome number leads to polyploidy and aneuploidy which in turn can contribute to 
the increased frequency of tumours observed in Plk4+/‘ mice.
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Thus, Plk4 plays a crucial role in centrosome duplication however it is not the 
sole regulator of this phenomenon. Plk4 and Cdk2 presumably cooperate in the 
centrosome duplication pathway.
The Plks and DNA Damage Pathways
One of the most important functions of Polo-like kinases is their involvement in 
DNA damage checkpoint pathways. Cell cycle checkpoints ensure that one stage of the 
cell cycle is completed at high fidelity prior to the initiation of the following stage. A 
loss of checkpoint function can result in genetic instability and/or transformation (Xie et 
al., 2005). Plk 1, 2 and 3 are key proteins that are important to cell cycle regulation and 
have been implicated in DNA damage checkpoint pathways.
Plkl has been shown to physically bind to tumour suppressor p53 and inhibit its 
transcriptional activity. However, upon DNA damage to the cells, critical DNA damage 
sensor proteins are activated such as ataxia telangiectasia mutated protein (ATM) and 
ATM- and Rad3-related protein (ATR). In turn, these kinases phosphorylate downstream 
targets including the polo-like kinases. Plkl has been shown to be inhibited by ATM and 
ATR and thus is inhibited by DNA damage (Smits et al., 2000). This inhibition of Plkl 
by ATM and ATR abolishes P lk l’s inhibition of p53 and as a result p53 levels can 
increase leading to cell cycle arrest or apoptosis. Although these observations implicate 
Plkl as a negative regulator of DNA damaged cell cycle arrest, Plkl may also play a 
positive role in DNA damage checkpoint activation. Plkl has been shown to 
phosphorylate and possibly activate Chk2 (Tsvetkov et al., 2003) which ultimately leads 
to the inactivation of Cdc25C and thus entry into mitosis can no longer occur.
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Other mammalian Plks have also been implicated in the DNA damage checkpoint 
activation pathway. Plk2 mRNA expression is increased in response to cellular stresses 
such as UV damage and this response is dependent on p53 expression. Additionally, p53 
binds to the Plk2 promoter and induces transcription (Bums et al, 2003).
In sharp contrast to Plkl, Plk3 acts as a positive regulator of DNA damage 
pathway activation. Plk3 has been shown to interact and activate p53 and the degree of 
this interaction is increased in response to DNA damage. Also in response to DNA 
damage, Plk3 is activated in an ATM-dependent manner (Xie et al, 2001). Additionally, 
Plk3 has been shown to phosphorylate and activate Chk2 in concert with ATM (Bahassi 
et al, 2002). Thus Plks 1, 2 and 3 all play significant roles in DNA damage response 
pathways (Figure 4).
Plk4 has also recently been implicated in DNA damage pathways. The protein 
has been shown to co-immunoprecipitate with p53 (Swallow et al, 2005). Furthermore, 
through chip profiling Li et al, 2005 have shown that p53 repressed Plk4, through an 
indirect mechanism as direct binding of p53 to the Plk4 promoter region was not seen. 
Plk4 expression was repressed in a p53-dependent manner such that when cells were 
exposed to etoposide to activate p53, a dramatic decrease in Plk4 expression was seen in 
p53 wildtype cells however not in p53 null cells. This indicates a direct relationship 
between p53 status and downregulation of Plk4 expression. Lastly, Li et al, 2005 
showed that Plk4 RNAi induced apoptosis, whereas overexpression of the protein 
attenuated p53-mediated apoptosis indicating that Plk4 repression likely contributes to 
p53-induced apoptosis. Thus, the role of Plk4 in DNA damage has yet to be clearly 
defined and the role this kinase plays in response pathways remains to be elucidated.
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Figure 4. Major DNA damage pathways where Plks have been implicated. Solid 
red arrows indicate positive regulation whereas solid black lines indicate negative 
regulation. Dotted lines indicate proposed regulatory role however the precise role 
remains to be elucidated.
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The Plks and Entry into Mitosis
Mitotic entry requires the activation of the Cdkl /Cyclin B complex in eukaryotic 
cells. The kinase activity of Cdkl /Cyclin B is controlled by phosphorylation and 
dephosphorylation events on Cdkl and the accumulation of Cyclin B protein. Mytl and 
Weel protein kinases phosphorylate Thrl4 and Tyrl5 respectively on Cdkl (Russell and 
Nurse, 1987; McGowan and Russell, 1993; Mueller et al., 1995). Phosphorylation on 
these residues is inhibitory due to the blocking of ATP binding sites (Artherton-Fessler et 
al., 1993). Upon completion of G2, dephosphorylation of inhibitory sites on Cdkl by 
Cdc25C triggers the activation of the Cdc2/Cyclin B complex (Nishida et al., 2002). 
Furthermore, phosphorylation of Cdkl is also needed to activate the kinase. In addition 
to the accumulation of Cyclin B and activation of Cdc2, nuclear localization of 
Cdc2/Cyclin B and Cdc25C are thought to be essential for the induction and coordination 
of M-phase events (Li et al., 1997). During interphase, Cdc25C is mainly cytoplasmic 
due to the phosphorylation of S216 by checkpoint kinases Chkl/2 and CTAK-1 which 
creates a binding site for 14-3-3 protein (Peng et al., 1997). Similarly to Cdc25C, Cyclin 
B is also cytoplasmic during interphase due to the existence of a cytoplasmic retention 
sequence and a nuclear exclusion motif (Hagting et al., 1999). During mitosis, Cdc25C 
and Cyclin B are both localized to the nucleus. Activation of these proteins and 
localization to the nucleus is done primarily through phosphorylation of key residues on 
the protein (Li et al., 1997). Although it is thought that one of the enzymes which 
activates Cdc25C at G2/M is Cdkl (thus creating a positive feedback loop), other 
activating kinases of Cdc25C exist (Peng et al., 1997). Cyclin B1 is thought to be 
phosphorylated in the nuclear exclusion motif at four conserved residues which promotes
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nuclear import. Mutation of these four residues (Ser 126, 128, 133 and 147) to alanine 
abolishes the nuclear import of the protein (Hagting et al, 1999). Furthermore, although 
initial activation of Cdkl/Cyclin B occurs at the centrosomes, many of the kinases 
responsible for this activation remain to be elucidated (Hagting et al., 1999). The polo­
like kinases are one group of kinases that have been implicated in the phosphorylation 
and localization of Cdc25C and Cyclin B.
Plx, the Xenopus polo-like kinase family member, was the first to be implicated in 
the interaction with Cdc25C and Cyclin B (Abrieu et al., 1998). Abrieu et al., 1998 
showed through immunodepletion studies that Plx is indeed indispensable for activation 
of Cdkl/Cyclin B. Furthermore, the study showed that the Cdkl/Cyclin B complex 
promotes activation of Plx which in turn leads to Cdc25C activation. As mentioned, 
Cdc25C activation leads to the dephosphorylation and activation of Cdkl/Cyclin B thus 
creating a positive feedback loop (Abrieu et al., 1998).
Plk4 family members Plkl and Plk3 both have significant roles in the entry into 
mitosis. Roshak et al., 2000 showed that Plkl phosphorylates Cdc25C; however which 
sites Plkl phosphorylates was not determined. Phosphorylation of Cdc25C by Plkl 
resulted in the activation of this phosphatase as was assessed by dephosphorylation of 
Cdkl/Cyclin B (Roshak et al., 2000). Additionally, Toyoshima-Morimoto et al., 2002 
showed that Plkl phosphorylates S I98 of Cdc25C which is located in the nuclear export 
signal of the phosphatase, leading to nuclear localization of the protein. One possibility 
for the nuclear accumulation of Cdc25C is that phosphorylation of S I98 of Plkl inhibits 
14-3-3 binding. Furthermore, an interaction between Plkl and Cyclin B has also been 
determined. Plkl phosphorylates Cyclin B1 on a serine residue (SI47) in the nuclear
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export signal, and induces its nuclear entry during prophase (Toyoshima-Morimoto et al, 
2001).
Bahassi et al., 2004 have shown that Plk3 co-fractionates and co- 
immunoprecipitates with Cdc25C. Furthermore, they have shown that Plk3 
phosphorylates Cdc25C on S I91, and to a lesser extent on S I98, sites located within the 
proteins nuclear exclusion motif. Mutation of S I91 to alanine abolishes the localization 
(Bahassi et al„ 2004). Furthermore, overexpression of wildtype Plk3 induces nuclear 
accumulation of Cdc25C however this accumulation is however not seen with 
overexpression of kinase-dead Plk3. Nuclear accumulation of Cdc25C is abrogated when 
Plk3 is inhibited with siRNA further supporting Plk3’s involvement in Cdc25C 
phosphorylation and nuclear localization (Bahassi et al, 2004).
Evidence suggests that Plk4 kinase regulates both Cdkl and APC/C and thus 
suggests a possible role for Plk4 in the entry and perhaps exit from mitosis. Plk4 
heterozygous hepatocytes also have a loss of acuity of Cyclin B1 levels suggesting a 
further role of Plk4 in entry into mitosis. Plk4 is primarily found to localize to 
centrosomes, the site at which activation of Cdkl/Cyclin B initially occurs (Jackman et 
al, 2003). These observations along with Plk4 family member’s interactions with 
Cdc25C and Cyclin B1 suggest a possible role for Plk4 in entry into mitosis.
Therefore, given that Plk4 family members play key roles in DNA damage 
checkpoint responses and mitotic entry, the purpose of the present study is to elucidate a 
role for Plk4 in DNA damage pathways and entry into mitosis.
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CHAPTER II 
MATERIALS AND METHODS
Production of Competent Escherichia coli (E. coli) cells
In order to obtain competent E. coli for subsequent transformation the procedure outlined 
below was followed. 10 mLs of TYM broth in a 50 mL flask was inoculated with E coli 
cells from glycerol stocks and grown for 16 hours at 37°C. 1 mL of the resultant culture 
was added to 100 mL prewarmed TYM broth in a 500 mL flask and grown at 37°C until 
an OD600 of 0.5 was reached. Cultures were then cooled on ice with gentle swirling for 
five minutes and then transferred to a sterile, round-bottom centrifuge tube. The cells 
were centrifuged for 10 minutes at 4000 x g  at 4°C, the supernatant decanted and the 
pellet resuspended gently in 30 mL cold TFB1. The cells were then collected by 
centrifugation for 10 minutes at 4000 x g  at 4°C with the supernatant carefully discarded. 
Bacterial cells were kept on ice throughout the procedure. The cells were then 
resuspended in 4 mL ice-cold TFB2 buffer and 100 uL aliquots were placed in sterile 
microcentrifuge tubes. The aliquots were frozen in liquid nitrogen and stored at -80°C.
Transformation and DNA purification
In order to obtain plasmid DNA needed for subsequent experimental procedures, 
competent E-coli cells (ToplO F’) were transformed as follows: Approximately 10-100 
ng of plasmid DNA was added to the competent cells and incubated on ice for 30 
minutes. Following this, the cells were heat shocked at 42°C for 40 seconds and then 
placed immediately back on ice. 500 uL of Luria-Bertani (LB) broth was then added and
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the cells were incubated at 37°C for 45 minutes. 100 uL of cells were subsequently 
plated on LB agar plates supplemented with 100 ug/mL ampicillin and incubated over 
night at 37°C. The following day, a single colony was inoculated with 100 mL LB 
supplemented with 100 ug/mL ampicillin and grown for 16 hours at 37°C. The DNA was 
purified using a QIAGEN Plasmid Maxi Prep Kit (Qiagen Inc.) in compliance with the 
manufacturer’s specifications.
Cell Culture
HEK-293 and NIH-3T3 cells were maintained in Dulbecco’s Modified Eagle’s Medium 
(Sigma) supplemented with 10% fetal bovine serum (Sigma). In order to aid in the 
prevention of contamination the media was also enriched with penicillin (100 U/mL) / 
streptomycin (100 ug/mL) (Gibco), amphotericin B (2.5 ug/mL) (Mediatech) and 
gentamycin (50 ug/uL) (Hyclone). Cell cultures were maintained at 37°C with 5% CO2 .
Transfection and Cell Lysis
Twenty-four hours prior to transfection, cells were seeded onto 100 mm tissue culture 
dishes at a density of lxlO6 cells / dish (~20-40% confluence). Cells were routinely 
transiently transfected with approximately 6ug of the FLAG vector (Invitrogen) using 
Effectene transfection reagent (Qiagen Inc.) in compliance with the manufacturer’s 
specifications. All other FLAG-tagged constructs were transfected using equimolar 
amounts relative to the vector control. At the indicated times post transfection, cells were 
washed three times with ice cold PBS and then lysed on ice for 20 minutes with 1 mL 
lysis buffer. Cells were then scraped off the plate and lysates were clarified by
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centrifugation for 20 minutes at 13,000 x g  at 4°C.
UV and IR damage
In order to induce DNA damage, cells were exposed to ultra-violet radiation at the 
indicated doses using a Stratalink UV crosslinker (Stratagene), or similarily, cells were 
exposed to the indicated doses of ionizing radiation (Faxitron X-ray Corp., R650). Cells 
were then incubated at 37°C with 5% CO2 for the indicated times (6 or 16 hours) and 
lysed as previously described. Following lysis, immunoprecipitation, Western blot 
analysis or flow cytometry analysis was performed.
Antibodies
For immunoprecipitation reactions, 1 ug of anti-Cdc25C (Santa-Cruz), anti-FLAG 
(Sigma) or anti-Cyclin B1 (Sigma) were incubated with 1 mg of lysate. For Western blot 
analyses, 1 ug of the specified primary antibody was incubated in 10 mL of TBST and a 
dilution of 1:60000 was used for the appropriate anti-mouse or anti-rabbit secondary 
antibodies which were conjugated to horseradish peroxidase (HRP) (Amersham). This 
was dependent on the species of the primary antibody. Alternatively, protein A HRP 
(Amersham) was used as secondary antibody at a dilution of 1:10000.
Immunoprecipitation
Following cell lysis and centrifugation, immunoprecipitation of FLAG-tagged expression 
plasmids and endogenous Cdc25C and Cyclin B1 was performed by incubating 
approximately 1 mg of lysate with 1 ug of the indicated antibody for 1 hour at 4°C on a
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vertical rotator. Immunocomplexes were then precipitated with 60 uL of a 20% protein 
G-sepharose slurry (GE lifesciences) at 4°C for one hour. Following the one hour 
incubation with the protein G-sepharose beads, the immunocomplexes were pelleted at 
13,000 x g  at 4°C for 1 minute. The precipitates were then washed three times at 4°C 
with 500 uL of TNT buffer. Following this, the immunoprecipitates were resuspended in 
15 uL of 2X SDS sample buffer and boiled for 5 minutes. The proteins were then 
separated by SDS-polyacrylamide gel electrophoresis and Western blot analysis was 
performed.
Western Blotting
Cell lysates and immunocomplexes were resupended in 20 uL of sodium dodecyl 
sulphate (SDS) sample buffer and incubated at 100°C for five minutes. Proteins were 
then resolved by SDS-polyacrylamide gel electrophoresis. Gels were subsequently 
incubated in transfer buffer for 15 minutes at room temperature on a shaker. In the 
meantime, polyvinylidene fluoride (PVDF) membrane was activated with methanol for 
20 seconds and then equilibrated for 10 minutes in transfer buffer. Transfer of the 
proteins from the gel to the membrane was done using a semi-dry transfer apparatus 
(Biorad). Three whatman filters were immersed in transfer buffer and then placed on the 
transfer apparatus. PVDF membrane was then placed on top of the three filters and the 
gel was placed on top of the membrane. Three additional whatman filters were immersed 
in transfer buffer and then placed on top of the gel. The filters were then hand rolled to 
ensure no air bubbles were trapped in any layer. The gel was transferred to the 
membrane at a suitable voltage and time depending on the number of membranes
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transferred. Following transfer of the proteins to the PVDF membrane, the membrane 
was blocked using TBST for one hour at room temperature in order to reduce non­
specific binding sites on the membrane. Following blocking, the membrane was 
incubated with primary antibody for one hour. The membrane was then washed three 
times for ten minutes and subsequently incubated with the appropriate secondary 
antibody which was conjugated to horseradish-peroxidase for 45 minutes. After an 
additional three 10 minute washes with TBST, the proteins of interest were visualized 
using enhanced chemiluminscent substrate (Pierce).
Flow Cytometry
For cell cycle analysis purposes, a flow cytometer (Beckman Coulter, FC500) was 
utilized. Cells were prepared as follows: At the indicated times post transfection, NIH- 
3T3 cells were collected and pelleted at 500 x g for 5 minutes. Cells where then washed 
with 10 mL room-temperature PBS and pelleted again at 500 x g  for 5 minutes. 
Supernatant was carefully removed and cells were fixed by resuspending in 1 mL 3.7% 
paraformaldehyde and kept on ice for 1 hour. Cells were then centrifuged at 500 x g  for 
5 minutes and washed in 10 mL cold PBS. Supernatant was removed and cells were 
resuspended in 1 mL cold 70% ethanol and kept on ice for 1 hour. Cells were then 
pelleted at 500 x g  for 5 minutes, resuspended in 1 mL PBS and DNA was stained with 
10 uL of propidium iodide (5 mg/mL stock) for 1 hour at room temperature.
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GST-Cdc25C Protein Purification
To maximize expression of recombinant proteins E. coli BL21 cells were utilized which 
allow for optimal expression of recombinant protein. E. coli BL21 backgrounds are 
deficient in a number of proteases. This allows them to accumulate recombinant proteins 
at a high rate and help reduce the degradation of some proteins during purification. 
Therefore the pGEX2T-Cdc25C plasmid was introduced into this cell type by 
transformation (see above). A single colony was inoculated overnight in 50 mL of LB 
supplemented with 100 ug/mL of AMP. The following day 1 L of LB was inoculated 
with 10 mL of overnight culture. Cultures were grown at 37°C to an Agoo of 0.6 and 
IPTG (Fisher) was added to a final concentration of 0.5 mM. The temperature was then 
dropped to 25°C to improve solubility of the protein, and the cultures were induced for 
another 16 hours. Cells were then pelleted at 5000 x g for 15 minutes at 4°C, the 
supernatant discarded and the cells were resuspended in 20 mL cell lysis buffer. The 
cells were then sonicated on ice, centrifuged at 10 000 x g  for 30 minutes at 4°C, and the 
supernatant was added to a column containing GST-agarose beads. The column was then 
placed on a vertical rotator for four hours to allow the protein to bind to the beads. The 
supernatant was then allowed to flow through the column and the beads were washed two 
times with column wash buffer. 3 mL’s of elution buffer were added to the column and 
incubated at 4°C overnight. The following day, the protein was eluted. SDS-PAGE and 
Western blot analyses were performed to visualize the purified protein.
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Kinase Assay
In order to detect Plk4 kinase activity, HEK-293 cells were transiently transfected with 
FLAG-Plk4, FLAG-K41M and FLAG-T170D expression plasmids. 16 hours post 
transfection cells were lysed and the cell lysate was incubated with 1 ug anti-FLAG 
antibody at 4°C for 45 minutes and precipitated with 60 uL of a 20% protein G-sepharose 
slurry (GE lifesciences) at 4°C for 45 minutes. The immunoprecipitates were washed 
three times in TNT buffer and once in kinase buffer. The immunocomplexes were 
resuspended in 20 uL of kinase buffer and the reaction was started by incubation with 10 
uCi [y-32P] ATP (Amersham Biosciences) and 5 ug of GST-Cdc25C. After incubation 
for 45 minutes at 30°C, 20 uL of 2X SDS sample buffer was added to stop the reaction. 
Samples were boiled for 5 minutes and then analyzed by SDS-polyacrylamide gel 
electrophoresis. The gel was then transferred to a membrane and a phosphoimager was 
utilized to visualize the bands. Following this, the membrane was then probed with an 
anti-FLAG antibody in order to detect the immunoprecipitated protein. The same blot 
was subsequently probed with an anti-Cdc25C antibody to confirm equal loading of the 
protein.
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CHAPTER III 
RESULTS
Plk4 and DNA Damage pathways
UV Radiation Inhibits Plk4 Protein Expression
On the basis of the role of Plkl, 2 and 3 in DNA damage pathways and the 
interaction of Plk4 with checkpoint effector p53, the effects of DNA damage on Plk4 
protein expression was investigated. To this end, NIH-3T3 cells were transiently 
transfected with an expression plasmid for FLAG-Plk4. 16 hours post transfection, cells 
were exposed to varying doses of ultra-violet (UV) and ionizing radiation (IR). Six hours 
post irradiation, cells were lysed and immunoprecipitation was done using an anti-FLAG 
antibody. As can be seen in Figure 5, with increasing doses of UV radiation, Plk4 protein 
expression decreases. At a dose of 70mJ/cm2 Plk4 protein was no longer present.
In order to determine if the decrease in protein levels found with increasing doses 
of UV radiation also occurred with other types of DNA damage, Plk4 protein levels were 
examined in response to ionizing radiation. NIH-3T3 cells were transiently transfected 
with FLAG-Plk4 and exposed to increasing doses of ionizing radiation. Six hours post 
irradiation, cells were lysed and immunoprecipitation using an anti-FLAG antibody was 
performed to examine Plk4 protein levels. Surprisingly, Plk4 protein levels remained 
constant with increasing doses of ionizing radiation (Figure 6).
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Figure 5. Plk4 protein levels decrease with increasing doses of UV radiation.
NIH-3T3 cells were transiently transfected with an expression plasmid for Flag-Plk4. 
16 hours post transfection cells were exposed to increasing doses of UV radiation. 
Cells were incubated for another six hours and then lysed. Immunoprecipitation and 
Western blot analysis were performed using an Anti-Flag antibody. Lysates were 
probed with an anti-GAPDH antibody as a loading control.
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Figure 6. Plk4 protein levels remain constant with increasing doses of IR. NIH- 
3T3 cells were transiently transfected with Flag-Plk4. 16 hours post transfection cells 
were exposed to increasing doses of IR. Cells were incubated for another six hours 
and then lysed. Immunoprecipitation and Western blot analysis were performed using 
an anti-Flag antibody. Cell lysates were probed using an anti-GAPDH as a loading 
control.
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Overexpression o f Plk4 Causes Recovery from DNA Damage Induced Cell Cycle Arrest 
To further investigate the function of Plk4 in DNA damage response pathways, 
the role of Plk4 in cell cycle arrest after DNA damage was investigated. To explore this,
NIH-3T3 cells were transfected with an expression plasmid for GFP-Plk4. Untransfected
# 2
cells were used as a control. 10 hours post transfection cells were exposed to 20 mJ/cm
of UV radiation or left untreated and 16 hour post irradiation cell cycle profiles were 
analyzed using a flow cytometer. A dose of 20 mJ/cm2 was chosen since the cells did not 
undergo apoptosis 16 hours post UV radiation at this dose. Furthermore, examining the 
previous experiment, Plk4 protein still persists at this dose. Examining Figure 7A, non­
transfected, non-treated control cells had a similar cell cycle profile to non-treated cells 
over-expressing Plk4. This thus suggests that Plk4 overexpression in the absence of 
DNA damage does not disturb the cell cycle. In the non-transfected control cells, 16 
hours post irradiation approximately sixty percent of the cells remained arrested in G0/G1 
and forty percent in G2/M thus exhibiting cell cycle arrest as would be expected with 
DNA damage (Figure 8). In contrast, in cells that overexpress Plk4 protein, a strikingly 
different cell cycle profile was obtained upon exposure to UV damage. Interestingly, 
when cells overexpressing Plk4 were subjected to radiation, rescue of the cell cycle block 
imposed by DNA damage was observed (Figure 7B). Cells that were overexpressing 
Plk4 pushed the cell cycle through the Gl-S cell cycle block and lead to an accumulation 
of cells in the S phase of the cell cycle however almost no cells were seen in G2/M 
(Figure 7B).
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Figure 7. Overexpression of Plk4 causes recovery from DNA damage induced cell 
cycle arrest. The experiment was repeated three times and shown here is 
representative data from one trial. A. NIH-3T3 cells were transiently transfected with 
an expression plasmid for GFP-Plk4 or left untransfected. Cell cycle analysis was 
done in the absence of DNA damage. B. Cells were transiently transfected with GFP- 
Plk4 or left untransfected. 10 hours post transfection cells were exposed to 20mJ/cm2 
of UV or left untreated. The cells were then incubated for another 16 hours following 
which cell cycle analysis was performed using flow cytometry.
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Analysis of Cell Cycle Data Post-UV Irradiation
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Figure 8. Analysis of Cell Cycle Data Post-UV Irradiation. With no irradiation, 
both transfected and non-transfected cells exhibited normal cell cycle profiles. 
However, 16 hours post irradiaton, non-transfected cells were blocked in the cell 
cycle, whereas GFP-Plk4 transfected cells did not exhibit DNA damage induced cell 
cycle arrest. The experiment was repeated three times.
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Plk4 and Entry into Mitosis
Interaction o f  Plk4 with Cyclin B1
Plkl has been shown to phosphorylate SI47 in the nuclear export signal of Cyclin 
B1 and induce the proteins nuclear translocation (Toyoshima-Morimoto et al, 2001). 
This observation of Plkl prompted us to investigate a possible interaction between Plk4 
and Cyclin B l. To further investigate this possibility, HEK-293 cells were transiently 
transfected with expression plasmids for FLAG-tagged Plk4 domain specific constructs 
(Figure 9). The expression of the FLAG constructs was confirmed in cell lysate by 
immunoblot analysis with an antibody against the FLAG epitope followed by probing 
with an anti-GAPDH antibody to confirm equal protein loading (Figure 10A). Whole 
cell lysates prepared from transfected cells were immunoprecipitated with an anti-Cyclin 
Bl antibody and Western blot analysis was performed using an anti-FLAG antibody. As 
shown in Figure 10B, FLAG-Plk4, FLAG-154N, FLAG-APb, FLAG-K41M and FLAG- 
T170D were co-immunoprecipitated with the endogenous Cyclin B l. However, co- 
immunoprecipitation of deletion constructs FLAG-R1 or FLAG-Pb was not seen with 
Cyclin Bl (Figure 10B). FLAG-YVHI was used as a negative control to ensure that the 
interaction which was observed was not due to the FLAG-tag. After probing with an 
anti-FLAG antibody to show co-immunoprecipitation with cyclin B l, the membrane was 
stripped and probed with an anti-Cyclin Bl antibody to ensure an equal amount of protein 
was immunoprecipitated. These results clearly demonstrate that Plk4 interacts with 
Cyclin Bl however the polo-box domain is not necessary for this interaction to occur. 
Furthermore, the cryptic polo-box or the polo-box domain are not sufficient for this
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interaction to occur, suggesting that perhaps the interactions of sub-domains of Plk4 are 
necessary for this interaction to occur.
Kinase Domain Cryptic-Pb Polo-Box KDa
WT (1-970)
APb (1-839)
R1 (596-836) 
Pb (839-925)
T170D
K41M
D154N
100j  |  Wild-type Plk4
Plk4 minus the polo-box domain 85
n
Cryptic polo-box of Plk4 30
18Polo-box region o f Plk4 
Activating mutation in the T-loop 100
100Inactivating mutation in the 
ATP binding domain
Inactivating mutation in the 
kinase domain
100
Figure 9. PIk4 domain specific constructs. A schematic representation of Plk4 
deletion mutants and Plk4 kinase dead and kinase active mutants.
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Figure 10. Plk4 co-immunoprecipitates with endogenous Cyclin B l. HEK-293 
cells were transiently transfected with expression plasmids for FLAG-Plk4 proteins. 
16 hours post transfection cells were lysed. (A) Lysates of transfected proteins were 
immunoblotted with an anti-FLAG antibody to determine the transfection efficiency 
and then probed with anti-GAPDH to ensure equal protein loading.
(B) Immunoprecipitation was performed using an anti-Cyclin Bl antibody. The 
immunocomplexes were resolved by SDS-PAGE and immunoblotted with anti-FLAG 
antibody. Full length Plk4, kinase dead Plk4 (K41M), kinase active Plk4 (T170D), 
APb-Plk4 (deletion of polo-box domain of Plk4) and an alternate kinase dead Plk4 
(154N) all co-immunoprecipitated with endogeous Cyclin B l. Co- 
immunoprecipitation of the deletion constructs, cryptic-polo-box domain (Rl) and the 
polo-box domain (Pb) was not observed. Whole cell lysates of non-transfected cells 
and the transfected construct encoding FLAG-YVHI protein served as negative 
controls. After immunoblotting with an anti-FLAG antibody to show the interaction, 
the membrane was stripped and reprobed with an anti-Cyclin Bl antibody.
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Interaction o f  Plk4 with Cdc25C
Nuclear localization of Cdc25C plays an essential role in maintaining the activity 
of Cdc2/Cyclin B in the nucleus during mitosis by counteracting inhibitory 
phosphorylation (Toyoshima-Morimoto et al., 2002). Plkl and Plk3 have both been 
shown to phosphorylate phosphatase Cdc25C. These observations prompted us to 
investigate possible interactions between Plk4 and Cdc25C. For this purpose, HEK-293 
cells were transiently transfected with expression plasmids for FLAG-tagged Plk4 
domain specific constructs. Cell lysates were initially probed with an anti-FLAG 
antibody to ensure expression of the plasmids followed by probing with a GAPDH 
antibody to ensure equal protein loading (Figure 11 A). Whole cell lysates prepared from 
the transfected cells were immunoprecipitated with an anti-Cdc25C antibody and 
Western blot analysis was performed using an anti-FLAG antibody. Similar to the results 
observed with the Cyclin Bl co-IP, FLAG-Plk4, FLAG-154N, FLAG-APb, FLAG- 
K41M and FLAG-T170D were co-immunoprecipitated with endogenous Cdc25C. Non­
transfected cell lysate and FLAG-YVHI were used as negative controls (Figure 1 IB). 
Co-immunopreciptation of the deletion constructs FLAG-R1 and FLAG-Pb was not 
observed (Figure 11B). After the initial Western blot analysis using the anti-FLAG 
antibody was performed to show the interaction between these two proteins, the 
membrane was stripped and probed with anti-Cdc25C to ensure equal amounts of protein 
was immunoprecipitated (Figure 11B). These results confirm that Plk4 interacts with 
Cdc25C while in the case of both the polo-box domain and the cryptic-polo box no 
interaction was detected.
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Figure 11. Plk4 co-immunoprecipitates with endogenous Cdc25C. HEK-293 cells 
were transiently transfected with expression plasmids encoding FLAG-Plk4 protein. 
16 hours post transfection cells were lysed. (A) Whole cell lysates were 
immunoblotted with an anti-FLAG antibody to show the levels of FLAG-tagged 
proteins, followed by probing with an anti-GAPDH antibody to confirm equal protein 
loading. (B) Immunoprecipitation was performed using an anti-Cdc25C antibody on 
prepared lysates and western blotting was perfomed using an anti-FLAG antibody. 
Full length Plk4, kinase dead Plk4 (K41M), kinase active Plk4 (T170D), APb-Plk4 
(deletion of polo-box domain of Plk4) and an alternate kinase dead Plk4 (154N) all co- 
immunoprecipitated with endogeous Cdc25C. Co-immunoprecipitation of the deletion 
constructs, cryptic-polo-box domain (Rl) and the polo-box domain (Pb) was not 
observed. Whole cell lysates of non-transfected cells and a transfected construct 
encoding FLAG-YVHI protein served as negative controls. The membrane was 
probed with an anti-Cdc25C antibody to ensure an equal amount of immunprecipitated 
protein.
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Plk4 Phosphorylates Cdc25C In-Vitro
The interaction of Cdc25C and Plk4 suggests the possibility that Cdc25C may be 
a substrate of Plk4. To test this hypothesis, firstly the GST-Cdc25C fusion protein was 
purified for use as substrate. To confirm the purity of the protein, SDS-PAGE was 
performed and the gel was Coomassie stained (Figure 12A). Immunoblotting was 
performed using an anti-Cdc25C antibody to further confirm the purity of the GST- 
Cdc25C protein. Purified GST-Cdc25C protein yielded primarily a protein product of 
83kDa and a 55 kDa proteolytically cleaved product, corresponding to the size of the 
cleaved Cdc25C protein (Figure 12B). FLAG-Plk4, FLAG-T170D and FLAG-K41M 
were transiently transfected into HEK-293 cells and immunoprecipitation was performed 
using an anti-FLAG antibody. The bacterially produced GST-Cdc25C was incubated 
with the respective FLAG-Plk4 immunoprecipitated constructs in the presence of [y- P] 
ATP and subjected to SDS-PAGE. Figure 12C shows that GST-Cdc25C is 
phosphorylated by FLAG-Plk4 and FLAG-T170D however not by the kinase dead Plk4 
mutant, FLAG-K41M. In addition to phosphorylation of the full-length GST-Cdc25C 
and GST-Cdc25C cleavage products, Plk4 autophosphorylation was observered as 
evident by the strong band at lOOkDa (Figure 12C). The membrane was probed with an 
anti-FLAG antibody to confirm the expression of FLAG-Plk4, then stripped and re­
probed with an anti-Cdc25C antibody to ensure equal protein loading (Figure 12D). 
These results show that Cdc25C is indeed a substrate of Plk4. Further experimentation is 
required to determine if  the site of phosphorylation is similar to that of Plkl or Plk3.
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Figure 12. Plk4 phosphorylates GST-Cdc25C. (A) GST-Cdc25C was expressed in and 
purified from bacteria using varying concentrations of IPTG. The fusion protein was purified 
using a GST column and SDS-PAGE was performed. Purification resulted primarily in an 
83kDa band corresponding to GST-Cdc25C and a band at 55kDa corresponding to cleaved 
Cdc25C. (B) Western blot analysis was performed with the fusion protein to ensure that the 
observed bands were in fact GST-Cdc25C. Varying dilutions of the protein were loaded onto 
a gel and SDS-PAGE was performed. GST-Cdc25C was detected using an anti-Cdc25C 
antibody. (C) Bacterially produced GST-Cdc25C was incubated with or without FLAG-Plk4 
in the presence of ATP, subjected to SDS-PAGE, transferred to a membrane and then 
analyzed using a phosphoimager (Alpha-Imager). (D) The membrane was then subjected to 
Western blot analysis with an anti-FLAG antibody to ensure transfection efficiency, and then 
stripped and re-probed with anti-Cdc25C to ensure equal protein loading.
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CHAPTER IV
DISCUSSION
One of the main roles of the polo-like kinase family is their involvement in DNA 
damage pathways. In response to DNA damage, Plkl activity is inhibited, whereas Plk3 
is activated (Xie et al., 2001; Ando et al., 2004). Since Plkl has been shown to 
phosphorylate and inactivate the tumour suppressor p53, the inhibition of Plkl activity in 
response to DNA damage consequently leads to the activation of p53 (Xie et al., 2001). 
Furthermore, Plk3 has been shown to phosphorylate and activate p53 and thus, activation 
of Plk3 in response to DNA damage leads to further p53 stabilization (Ando et al., 2004). 
Plk4 has also recently been implicated in DNA damage response pathways. An 
association between Plk4 and p53 protein has been established and the observation that 
p53 is a substrate of Plk4 has been previously documented (Swallow et al., 2005). Plk4 
has also been shown to be transcriptionally repressed by p53 and Plk4 mRNA levels 
decrease in response to DNA damage in a p53-dependent manner (Li et al., 2005). 
Although Plk4 mRNA levels in response to DNA damage have been previously 
examined, protein levels in response to damaged DNA have not been determined. To this 
end, it was of interest to determine if the protein level of Plk4 also decreased in response 
to DNA damage. Unfortunately, endogenous Plk4 protein levels could not be examined 
due to the unavailability of a suitable Plk4 antibody. Thus, Plk4 protein was 
overexpressed in NIH-3T3 cells and overexpressed protein levels were examined in 
response to DNA damage. Through Western blot analysis, it was determined that 
overexpressed Plk4 protein levels do indeed decrease with increasing doses of ultra-violet
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radiation, however protein levels remain constant in response to ionizing radiation. 
Although Li et al, 2005 observed a decrease in Plk4 mRNA levels in response to DNA 
damage in a p5 3-dependent manner, the decrease in protein levels observed with UV 
radiation cannot be explained by a decrease in the amount of translated protein since the 
NIH-3T3 cell line utilized is inactive in p53. Hence, this decrease in Plk4 protein level 
seen with UV radiation must occur through a p53 independent mechanism. One 
hypothesis for this could be that Plk4 protein is subjected to post-translational 
modification upon exposure to ultra-violet radiation and targeted for ubiquitin-mediated 
degradation. Also, it is interesting to note that the decrease in Plk4 protein was only seen 
with UV radiation however was not seen with ionizing radiation. An explanation for this 
observation could include that UV light and x-rays, which respectively induce pyrimidine 
dimers and DNA double strand breaks, use different signaling factors (Lakin et al., 
1999). For example, in response to ionizing radiation, ATM is activated; however, UV- 
damaged DNA activates ATR protein kinase (Lakin et al, 1999; Canmann et al., 1998; 
Tibbetts et al., 1999). Furthermore, in contrast to ionizing radiation, a role for p53 in 
response to UV radiation has not been clarified. UV radiation induces a G1 arrest in cells 
with wild-type p53. However surprisingly, this same G1 arrest is also seen in cells which 
p53 is inactivated (Chang et al., 1999). Thus, the decrease in Plk4 protein level must 
have occurred through a p53 independent mechanism and Plk4 conceivably acts through 
p53 dependent and p53 independent pathways.
Upon exposure of cells to DNA damage reagents, the genomic stability of cells is 
threatened. In order to effectively repair damaged DNA, and hence protect genomic 
integrity, cells undergo transient cell cycle arrests (Lindahl et al., 1993). The two major
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DNA damage cellular checkpoints occur at the Gl-S transition and at the G2-M transition 
(Kaufmann et al, 1996). These arrests allow cells time to repair the damaged DNA prior 
to replicating DNA or commencing mitosis. Cells which are exposed to the DNA 
damaging agents UV and ionizing radiation undergo G1 and G2 phase cell cycle blocks 
(Maki et al, 1997). These responses are under the control of a variety of genes which 
belong to different overlapping pathways. The Plk family has been implicated in the 
involvement of cell cycle arrest upon DNA damage. As previously stated, Plkl is 
inhibited in response to DNA damage (Ando et al., 2004). Furthermore, overexpression 
of Plkl was shown to overcome DNA damage cell cycle arrest (Smits et al., 2000). 
Since Plk4 has also been implicated in DNA damage response pathways, it was 
interesting to determine if Plk4 overexpression also pushes the cells through the cell 
cycle when exposed to DNA damage. Upon exposing untransfected cells to UV and 
ionizing radiation, an obvious G1 and G2/M cell cycle block was observed. Quite 
interestingly, overexpression of Plk4 rescued the cells from DNA damage induced cell 
cycle arrest. More specifically, these results indicate that overexpression of Plk4 appears 
to drive cells past the Gl-S DNA damage checkpoint and leads to the accumulation of 
cells in the S phase. Additionally, as is apparent by the absence of cells in G2/M, entry 
into G2/M is halted, however entry into G1 can still occur. One explanation for these 
observations could be that DNA damage inhibits Plk4, and overexpression of the protein 
overcomes this inhibition and drives cells past the Gl-S cell cycle checkpoint, suggesting 
a role for Plk4 in the entry into S phase. Moreover, this hypothesis is somewhat 
supported by the fact that overexpression of Plk4 leads to multiple centrosomes since 
centrosome duplication occurs in S phase (Habedanck et a l,2005; Hudson et al., 2001).
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Quite interestingly, Plk4 expression is increased in colorectal tumours (Macmillan et al, 
2001). One mechanism in which an increased expression of Plk4 could lead to tumour 
formation is if  overexpression of Plk4 pushes cells past the Gl-S checkpoint in the 
presence of damaged DNA, this could ultimately lead to genomic instability. A second 
mechanism in which Plk4 overexpression could lead to cancer may perhaps be the 
previously mentioned overduplication of centrosomes in the S phase which thus leads to 
aneuploidy. Consequently, the observation that overexpression of Plk4 drives cells past 
the Gl-S checkpoint has vast implications such that Plk4 overexpression could lead to a 
novel means by which chromosomal instability and eventually cancer occur.
Cdc25C is a key protein involved in mitotic entry. Moreover, this mitotic 
regulator serves as a target of checkpoint pathways delaying entry into mitosis in 
response to DNA damage or stalled replication. Under normal (non-stressful) conditions 
dephosphorylation and activation of the Cdkl/Cyclin B complex by phosphatase Cdc25C 
ultimately leads to mitotic entry (Dalai et al., 1999). Cdc25C localization and activation 
is dependent on phosphorylation and dephosphorylation events and many of the enzymes 
responsible for these events remain to be elucidated.
In interphase, Cdc25C is phosphorylated on S216 by CTAK-1 which allows for 
the binding of 14-3-3 protein and maintains cytoplasmic localization of this protein (Peng 
et al., 1997). Also in response to DNA damage, Cdc25C is phosphorylated by 
checkpoint kinases Chkl/2 on S216 which leads to the cytoplasmic localization and 
ultimately inactivation of this protein (Peng et al, 1997). However, upon completion of 
G2 Cdc25C is activated and localized to the nucleus. Phosphorylation of this protein is a 
key event leading to its nuclear accumulation (Dalel et al, 1999). Quite similar to
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Cdc25C, Cyclin Bl nuclear accumulation is also necessary for mitotic entry to occur. 
Interestingly, evidence indicates that the initial activation of the Cdkl/Cyclin B complex 
occurs at the centrosome (Jackman et al., 2003), the main site of Plk4 localization. To 
this end, it was of interest to determine if Plk4 interacted with these mitotic regulators 
and DNA damage checkpoint targets. Quite interestingly, full length Plk4 was found to 
co-immunopreciptate with both Cdc25C and Cyclin B l . Although the polo-box region of 
other Plk family members has been implicated as a phosphopeptide substrate binding 
motif (Hanisch et al, 2006), the polo-box region of Plk4 was not necessary or sufficient 
for this interaction to occur. A potential problem could arise when the reciprocal co- 
immunoprecipitations would be performed. Considering the molecular weight of 
Cdc25C is 55kDa, the signal corresponding to this protein would be masked by the IgG 
heavy chain. Attempts using protein-A as a secondary antibody in place of anti-rabbit 
proved unsuccessful and a prominent band masking the Cdc25C signal was detected in 
the non-transfected control lane (data not shown).
The association of Plk4 with these proteins indicates that Plk4 could regulate 
these mitotic proteins. Furthermore, it sheds light on a novel role for Plk4 in the entry 
into mitosis.
The interaction of Plk4 with Cdc25C suggests that Cdc25C may be a substrate of 
Plk4. Indeed, Cdc25C was found to be a substrate of Plk4 through in-vitro kinase assays. 
Transport of proteins which contain a nuclear export signal is often times modulated by 
phosphorylation of amino acids within this motif, leading to nuclear import (Schwindling 
et al., 2004). Phosphorylation of sites within the nuclear export signal of Cdc25C can 
abolish 14-3-3 binding and may ultimately lead to the nuclear accumulation of Cdc25C.
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As previously discussed, S216 phosphorylation of Cdc25C occurs in interphase and 
phosphorylation of this residue leads to binding with 14-3-3 protein and thus cytoplasmic 
localization (Peng et al., 1997). Quite interestingly, S191 and S198, residues found in the 
nuclear export signal of Cdc25C, are phosphorylated by Plkl and Plk3 and lead to the 
nuclear accumulation of the protein (Toyoshima-Morimoto et al, 2002; Bahassi et al., 
2003).
Although it has not been currently determined which sites Plk4 phosphorylates 
on Cdc25C, it was serendipitously determined that Plk4 phosphorylates a Cdc25C- 
derived peptide (Cell Signalling Technology, datasheet). Figure 13 shows the alignment 
of this peptide with a portion of the human Cdc25C protein. Intriguingly, this peptide 
corresponds to a region of the nuclear export signal of Cdc25C, which is the main motif 
responsible for Cdc25C nuclear import and export. Of the two serine residues found 
within the nuclear export signal of Cdc25C, S I91 but not S I98, is conserved in the 
peptide which was shown to be phosphorylated by Plk4 (Figure 13). These results 
suggest that Plk4, similar to its family members Plkl and Plk3 phosphorylate Cdc25C 
and furthermore, this phosphorylation event could perchance occur at S I91. Moreover, if 
Plk4 phosphorylates Cdc25C in its nuclear exclusion motif it could further promote 
nuclear accumulation of this protein.
Although the synthesis and destruction of regulatory proteins such as cyclins is 
important for cell cycle regulation, localization of these proteins to the right place at the 
right time is a fundamental step in ensuring proper cell cycle controls. Often times, this 
localization is accomplished through phosphorylation and dephosphorylation events.
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Thus, one hypothesis could be that Plk4 could act as an important coordinator for 
intracellular localization of Cdc25C to activate Cdc2/Cyclin B at the centrosomes.
Although further experimentation is necessary, a hypothesis for the observations 
observed could be that DNA damage may prevent activation of Cdc25C through 
inhibition of Plk4, if in fact Plk4 is an activating kinase for Cdc25C as is it’s family 
member Plkl (Toyoshima-Morimoto et al, 2002). Perhaps the inhibition of Plk4 has a 
critical role in establishing the cell cycle block seen after DNA damage. All of these 
results suggest that Plk4 inhibition is an important event in DNA damage-induced cell 
cycle arrest. On the basis of these findings, a possible model in which activation of 
Cdc25C is prevented in response to DNA damage through interference with Plk4 
activation is proposed (Figure 14).
Furthermore, the implications of these results are that Plk4 could thus, similar to 
its family members Plkl and Plk3, lead to the activation or inactivation of key mitotic 
regulators. The elucidation of proteins leading to the activation or inactivation of these 
mitotic proteins leads to a further understanding of the events which lead to cellular 
division. Uncontrolled cellular proliferation is a hallmark on the journey towards tumour 
development. Therefore further characterization of the key proteins involved in 
regulating cell proliferation will provide critical insight into identifying potential 
therapeutic targets for intervention.
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Figure 13. Alignment of Cdc25C-derived peptide and human Cdc25C protein.
The top panel (blue) depicts a partial sequence of the human Cdc25C protein. The 
nuclear export signal is blocked in grey. The bottom sequence depicts the Cdc25C- 
derived peptide implicated as a substrate of Plk4 {Cell Signalling Technology, 
datasheet). Asterisks (*) indicate Plkl and Plk3 phosphorylation sites.
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DNA D am age
H ATM/AT
/
Chk1/2 * *
M itotic Entry
Figure 14. A proposed pathway through which Plk4 acts.
Red lines indicate proposed positive regulation whereas black lines indicate proposed 
negative regulation. In this proposed model Plk4 is involved in the activation of 
Cdc25C which leads to mitotic entry. Thus, in response to DNA damage, activation o f  
Cdc25C is prevented through inhibition of Plk4 via ATM/ATR checkpoint kinases 
and mitotic entry is halted.
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CHAPTER V 
FUTURE DIRECTIONS
A reduction in overexpressed Plk4 protein level was observed in response to UV 
damage. Ideally, this experiment would be conducted looking at endogenous Plk4 
protein levels; however a suitable Plk4 antibody has yet to be optimized. Given that a 
reduction in overexpressed Plk4 protein level was seen in response to UV radiation and 
not ionizing radiation suggests a role for Plk4 in UV DNA damage pathways. Several 
unanswered questions remain and it would thus be interesting to explore if this decrease 
in protein level seen was in fact due to ubiquitination. In order to determine this, after 
transfection cells would be subjected to UV radiation at increasing doses. Six hours post 
radiation, cells would be lysed and immunoprecipitation would be performed using anti- 
FLAG antibody, followed by western blotting using an anti-ubiquitin antibody. It can 
also be further determined if this decrease in protein level was dependent on the 
proteasome, by using a proteasome inhibitor such as MG-132. If in fact this decrease in 
Plk4 protein was dependent on ubiquitin-mediated proteasomal degradation, the decrease 
in protein level would not be seen in the presence of this inhibitor. Ideally, this 
experiment would be performed using endogenous Plk4 protein, however at this time this 
is not an option due to the unavailability of a suitable Plk4 antibody. Additionally, seeing 
as this experiment was performed in NIH-3T3 cells, one can assume that the decrease in 
Plk4 protein level is occurring in a p53-independent manner since these cells contain 
inactive p53. Supporting this, a role for p53 has not been clarified in UV damage 
response pathways (Chang et al., 1999). However, Lie et al, 2005 determined that p53
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represses Plk4, thus implying Plk4 in p53-dependent and p53-independent response 
pathways. It would thus be interesting to test this experiment in a p53-null cell line such 
as Saos-2 and a p53 wildtype cell line such as U-20S, to see if this response is entirely 
p53 independent. Furthermore, Li et al., 2005 found that Plk4 mRNA levels decrease in 
cancer cell lines in response to the DNA damaging agent etoposide. To this end, it would 
be appealing to determine if UV and ionizing radiation in turn cause a decrease in Plk4 
mRNA level and a decrease in the kinase activity of the protein.
The observation that overexpression of Plk4 pushes cells through the Gl-S DNA 
damage checkpoint in the presence of damaged DNA suggests a possible role for Plk4 in 
the entrance into the S-phase of the cell cycle or possibly that Plk4 is inhibited in 
response to DNA damage. It would thus be of interest to determine if Plk4 
phosphorylates and activates (or inactivates) Cdk2 or Cyclin E leading to entry into S- 
phase. In order to determine this, co-immunoprecipitation assays would initially be done 
to show that Plk4 interacts with these proteins. Following this, in-vitro kinase assays 
could be performed to establish if Cdk2 and Cyclin E are in fact substrates of Plk4. The 
observation that the overexpression of Plk4 causes centrosome overduplication in the 
presence of Cdk2 (Habedanck et al., 2005) further supports this hypothesis.
One possible mechanism by which Plk4 is involved in mitotic entry is through 
interaction with key mitotic proteins Cdc25C and Cyclin B. These proteins are in turn 
targets of DNA damage pathways. Co-immunoprecipitations were initially done to 
determine that Cdc25C and Cyclin B interact with Plk4. Furthermore, it was determined 
that the polo-box domain was not necessary for these interactions to occur. It would 
however be interesting to determine if the ‘cryptic’ polo-box region of Plk4 is necessary
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for these interactions to occur. Additionally, whether Cdkl is an interacting partner of 
Plk4 and if Cyclin B is a substrate of Plk4 remain to be elucidated through co- 
immunoprecipitation experiments and in-vitro kinase assays.
Co-immunoprecipitation assays determined that Cdc25C is indeed an interacting 
partner of Plk4. Interestingly through in-vitro kinase assays, Cdc25C was found to be a 
substrate of Plk4. Therefore, it is of interest to establish which sites Plk4 phosphorylates 
on Cdc25C. This can be done by site directed mutagenesis of potential sites or truncation 
mutants of the phosphatase. Upon determining which sites Plk4 is responsible for 
phosphorylating the next question which needs to be answered is what effect this 
phosphorylation has on Plk4. For example, this site may lead to the activation of Cdc25C 
in turn leading to mitotic entry. On the contrary, Plk4 may inactivate Cdc25C (similar to 
Chkl) and prevent mitotic entry. If the site which is being phosphorylated is within 
Cdc25C’s nuclear exclusion motif, phosphorylation of this site may change the 
localization pattern of this protein. Perhaps this phosphorylation event leads to the 
accumulation of Cdc25C in the nucleus, similar to Plk4 family members Plkl and Plk3 
(Toyoshima-Morimoto et al., 2002; Bahassi et al., 2004). Phosphorylation of Cdc25C by 
Plk4, and interaction of Plk4 with Cyclin B, may suggest that Plk4 is important for 
mitotic entry and DNA damage response pathways.
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APPENDIX A: Solutions
LB Media (1L)
10 gtryptone 
5 g yeast extract 
lOgNaCl
Adjust pH to 7.0 and autoclave.
LB-AMP Plates (1L)
10 g tryptone 
5 g yeast extract 
lOgNaCl 
15g Agar
Autoclave and add AMP to a concentration of 100 ug/mL after cooling.
Lysis Buffer
50 mM Tris-HCl pH 7.4 
150 mMNaCl 
1 mM EDTA 
1% Triton X-100
1 protease inhibitor tablet (Roche) per 10 mL buffer
PBS
pH 7.4
137 mMNaCl 
2.7 mM KC1
4.3 mM Na2H P04
1.4 mM KH2P 0 4
TNT
0.1% Triton X-100 
50 mM Tris-HCl pH 7.4 
150 mMNaCl
Running Buffer
25 mM Tris 
250 mM Glycine 
0.1% SDS
Transfer Buffer (1 L)
3.03 g tris base
14.4 g glycine 
200 mL methanol
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2 X SDS-PAGE sample buffer (10 mL)
125 mM Tris pH 6.8
2.0 mL 100% glycerol
4.0 mL 10% (w/v) SDS
0.5 mL 0.1 % bromophenol blue
1 X TBST (Tris buffered saline and tween)
100 mM Tris-Cl pH 7.5 
150 mMNaCl 
0.1% Tween
Kinase Buffer
60 mM HEPES pH 7.5
3 mM MgCl2 
3 mM MnCl2 
50 mM NaF 
1.2 mM DTT
1 protease inhibitor tablet (Roche) per 10 mL buffer
GST-Protein Purification Buffers
Cell Lysis Buffer 
100 mMNaCl 
50 mM Tris pH 7.5 
0.1 mMEDTA 
0.1% Triton X-100
2 mM DTT
1 protease inhibitor tablet (Roche) per 10 mL buffer
Column Wash Buffer
100 mMNaCl 
50 mM Tris pH 7.5 
1 mM DTT
Elution Buffer
100 mMNaCl 
50 mM Tris pH 7.5 
10 mM Glutathione
Competent Cell Solutions
TFB1
30 mM KOAc 
50 mM MnC12
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100 mM KC1 
10 mM CaC12 
7% glycerol
TFB2
10 mM MOPS pH 7.0 
75 mM CaC12 
lOmMKCl 
7% glycerol
TYM broth
2% bactotryptone 
0.5% yeast extract 
0.1 MNaCl 
10 mM MgS04
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